These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8854256)

  • 1. Raloxifene analog (LY117018 HCL) ameliorates cyclosporin A-induced osteopenia in oophorectomized rats.
    Bowman AR; Sass DA; Marshall I; Ma YF; Liang H; Jee WS; Epstein S
    J Bone Miner Res; 1996 Aug; 11(8):1191-8. PubMed ID: 8854256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of testosterone in cyclosporine-induced osteopenia.
    Bowman AR; Sass DA; Dissanayake IR; Ma YF; Liang H; Yuan Z; Jee WS; Epstein S
    J Bone Miner Res; 1997 Apr; 12(4):607-15. PubMed ID: 9101372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
    Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
    J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17 beta-estradiol prevents osteopenia in the oophorectomized rat treated with cyclosporin-A.
    Joffe I; Katz I; Jacobs T; Stein B; Takizawa M; Liu C; Berlin J; Epstein S
    Endocrinology; 1992 Mar; 130(3):1578-86. PubMed ID: 1537307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bisphosphonate 2-PEBP inhibits cyclosporin A induced high-turnover osteopenia in the rat.
    Movsowitz C; Epstein S; Fallon M; Ismail F; Thomas S
    J Lab Clin Med; 1990 Jan; 115(1):62-8. PubMed ID: 2299257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption.
    Movsowitz C; Epstein S; Ismail F; Fallon M; Thomas S
    J Bone Miner Res; 1989 Jun; 4(3):393-8. PubMed ID: 2788358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 alleviates cyclosporin A-induced bone loss in the rat.
    Katz IA; Jee WS; Joffe II; Stein B; Takizawa M; Jacobs TW; Setterberg R; Lin BY; Tang LY; Ke HZ
    J Bone Miner Res; 1992 Oct; 7(10):1191-200. PubMed ID: 1456087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo.
    Katz I; Li M; Joffe I; Stein B; Jacobs T; Liang XG; Ke HZ; Jee W; Epstein S
    J Bone Miner Res; 1994 Jan; 9(1):59-67. PubMed ID: 8154310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment with cyclosporin A and cortisone acetate minimizes the adverse bone effects of either agent alone.
    Movsowitz C; Schlosberg M; Epstein S; Ismail F; Fallon M; Thomas S
    J Orthop Res; 1990 Sep; 8(5):635-41. PubMed ID: 2388102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat.
    Bryer HP; Isserow JA; Armstrong EC; Mann GN; Rucinski B; Buchinsky FJ; Romero DF; Epstein S
    J Bone Miner Res; 1995 Jan; 10(1):132-8. PubMed ID: 7747620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the rat.
    Epstein S; Dissanayake IR; Goodman GR; Bowman AR; Zhou H; Ma Y; Jee WS
    Calcif Tissue Int; 2001 Apr; 68(4):240-7. PubMed ID: 11353952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the T-lymphocyte in estrogen deficiency osteopenia.
    Sass DA; Liss T; Bowman AR; Rucinski B; Popoff SN; Pan Z; Ma YF; Epstein S
    J Bone Miner Res; 1997 Mar; 12(3):479-86. PubMed ID: 9076592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia.
    Mann GN; Jacobs TW; Buchinsky FJ; Armstrong EC; Li M; Ke HZ; Ma YF; Jee WS; Epstein S
    Endocrinology; 1994 Sep; 135(3):1077-83. PubMed ID: 8070349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The addition of a raloxifene analog (LY117018) allows for reduced PTH(1-34) dosing during reversal of osteopenia in ovariectomized rats.
    Hodsman AB; Drost D; Fraher LJ; Holdsworth D; Thornton M; Hock J; Bryant H; Watson PH
    J Bone Miner Res; 1999 May; 14(5):675-9. PubMed ID: 10320515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
    Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
    Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum bone gla protein and the vitamin D endocrine system in the oophorectomized rat.
    Ismail F; Epstein S; Fallon MD; Thomas SB; Reinhardt TA
    Endocrinology; 1988 Feb; 122(2):624-30. PubMed ID: 3257440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats.
    Marie PJ; Hott M; Modrowski D; De Pollak C; Guillemain J; Deloffre P; Tsouderos Y
    J Bone Miner Res; 1993 May; 8(5):607-15. PubMed ID: 8511988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive effects of clomiphene citrate on estrogen-deficiency osteopenia elicited by LHRH agonist administration in the rat.
    Goulding A; Fisher L
    J Bone Miner Res; 1991 Nov; 6(11):1177-81. PubMed ID: 1805541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alfacalcidol restores cancellous bone in ovariectomized rats.
    Li M; Healy DR; Simmons HA; Ke HZ; Thompson DD
    J Musculoskelet Neuronal Interact; 2003 Mar; 3(1):39-46. PubMed ID: 15758364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats.
    Sato M; Bryant HU; Iversen P; Helterbrand J; Smietana F; Bemis K; Higgs R; Turner CH; Owan I; Takano Y; Burr DB
    J Pharmacol Exp Ther; 1996 Oct; 279(1):298-305. PubMed ID: 8859007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.